Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 59 entries
View as:

Fixed-dose Combination of an Angiotensin Receptor Blocker and Thiazide Diuretic for Essential Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT06608472 Org: User:
Start: 11/30/26 End: 10/30/29 Due: 10/30/30

A Parallel-group Active Comparator, Double-blind, Multicenter, Randomized, Double-blind, Phase III Clinical Study

Phase: N/A Priority: Normal
NCT ID: NCT03936192 Org: User:
Start: 01/31/19 End: 02/28/21 Due: 02/28/22

Observational, Real-life, Retrospective, Data Collection, Use Sibutramine/topiramate in Overweight Comorbidities/obesity

Phase: N/A Priority: Normal
NCT ID: NCT05209997 Org: User:
Start: 12/01/24 End: 12/01/25 Due: 12/01/26

A Non-inferiority Study With Two Treatment Arms Eszopiclone 3 mg Versus Zopiclone 7.5 mg - for the Treatment of Insomnia

Phase: N/A Priority: Normal
NCT ID: NCT01100164 Org: User:
Start: 03/31/11 End: 04/30/12 Due: 04/30/13

Clinical Study, Non Inferiority Between Noex® 50µg Versus Busonid® 50µg in Treatment of Allergic Rhinitis

Phase: N/A Priority: Normal
NCT ID: NCT02988778 Org: User:
Start: 10/08/19 End: 10/08/19 Due: 10/08/20

Efficacy and Safety of Rizatriptan-Naproxen (10/550 Mg) in the Acute Treatment of Migraine

Phase: N/A Priority: Normal
NCT ID: NCT04384367 Org: User:
Start: 12/30/22 End: 11/30/24 Due: 11/30/25

Trial to Compare the Efficacy and Safety of Pegfilgrastim Biosimilar in Subjects With High Risk Stage Breast Cancer Receiving Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT02768714 Org: User:
Start: 01/31/18 End: 10/31/19 Due: 10/31/20

Study of New Antiandrogenic Progestogen + Low-dose Estrogen for Moderate Acne Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT06905210 Org: User:
Start: 03/31/26 End: 03/31/27 Due: 03/31/28

Study of Fluticasone/Formoterol/Glycopyrronium for the Treatment Chronic Obstructive Pulmonary Disease (TRIPLAR)

Phase: N/A Priority: Normal
NCT ID: NCT06234345 Org: User:
Start: 09/30/26 End: 08/31/28 Due: 08/31/29

A Multicenter, Randomized, Parallel, Two-period, Non-inferiority Study of EurofarmavsAlenia in Asthma and COPD Treatment

Phase: N/A Priority: Normal
NCT ID: NCT04233190 Org: User:
Start: 04/19/23 End: 10/30/24 Due: 10/30/25

A Study Comparative of Formoterol/Fluticasone Foraseq® and Fluticasone in Asthma Patients

Phase: N/A Priority: Normal
NCT ID: NCT01202084 Org: User:
Start: 01/31/12 End: 11/30/12 Due: 11/30/13

Efficacy and Safety of Two Fixed-dose Combinations in Men with Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia. (BENIPRO)

Phase: N/A Priority: Normal
NCT ID: NCT06546735 Org: User:
Start: 11/30/26 End: 08/30/28 Due: 08/30/29

Safety and Efficacy of Furosemide 40mg + Amiloride Hydrochloride 10mg to Reduct Edema

Phase: N/A Priority: Normal
NCT ID: NCT01210365 Org: User:
Start: 01/01/11 End: 03/31/13 Due: 03/31/14

Evaluation of the EF192B Protection Versus No Treatment

Phase: N/A Priority: Normal
NCT ID: NCT06752460 Org: User:
Start: 08/31/25 End: 10/31/25 Due: 10/31/26

UFH is the Most Used Anticoagulant in Hemodialysis, Decreasing the Risk of Clot Formation in the Circuit.

Phase: N/A Priority: Normal
NCT ID: NCT05148377 Org: User:
Start: 08/01/07 End: 12/01/08 Due: 12/01/09

Parallel, Double-dummy, Superiority Study Levocetirizine/Pseudoephedrine x Zina for Allergic Rhinitis in Brazil

Phase: N/A Priority: Normal
NCT ID: NCT05637710 Org: User:
Start: 03/31/26 End: 05/31/27 Due: 05/31/28

Study Comparing A New Drug Containing The Combination Meloxicam And Cyclobenzaprine In The Treatment Of Acute Lumbago

Phase: N/A Priority: Normal
NCT ID: NCT01587508 Org: User:
Start: 05/31/13 End: 05/31/13 Due: 05/31/14

A Non-inferiority, Multicenter and Randomized, Single-Dose Study About a Treatment to Hypolactasia (LAILAI)

Phase: N/A Priority: Normal
NCT ID: NCT01145339 Org: User:
Start: 07/31/11 End: 03/31/12 Due: 03/31/13

Comparison in the Treatment of Acute Cystitis Using Cephalosporin and Norfloxacin (CECI)

Phase: N/A Priority: Normal
NCT ID: NCT01527019 Org: User:
Start: 10/31/12 End: - Due: -

iSGLT2 Inhibitor and a iDPP -4 Inhibitor in Treatment of Type 2 Diabetes Mellitus in Patients Treated With Metformin (TRIAD)

Phase: N/A Priority: Normal
NCT ID: NCT06560333 Org: User:
Start: 11/30/26 End: 02/28/29 Due: 02/28/30

Non-Inferiority,Combination Formoterol/FluticasonexAlenia®Formoterol/Budesonide for Asthma in Brazil

Phase: N/A Priority: Normal
NCT ID: NCT05735431 Org: User:
Start: 06/30/26 End: 11/30/27 Due: 11/30/28

A Non-inferiority Study Comparing Two Filgrastim Preparations in Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01079676 Org: User:
Start: 03/31/11 End: 10/31/12 Due: 10/31/13

Study Comparing Radiation Therapy and Chemotherapy With or Without Nimotuzumab

Phase: N/A Priority: Normal
NCT ID: NCT01345084 Org: User:
Start: 11/30/13 End: 11/30/17 Due: 11/30/18

Phase 3 Clinical Trial to Evaluate Paracetamol /Fexofenadine /Phenylephrine in Flu and Cold Treatment

Phase: N/A Priority: Normal
NCT ID: NCT05118672 Org: User:
Start: 03/26/25 End: 08/31/25 Due: 08/31/26

Efficacy and Safety of Injectable Association of Dexamethasone, Dipyrone and Hydrocobalamin in Lumbar Sciatic Pain

Phase: N/A Priority: Normal
NCT ID: NCT01147289 Org: User:
Start: 02/28/11 End: 04/30/12 Due: 04/30/13